ALNY vs DLTH · P/E 76, rev $1.29B vs rev $565.2M
Alnylam Pharmaceuticals Inc (ALNY) versus Duluth Holdings Inc (DLTH) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Duluth Holdings Inc (DLTH) is a apparel retail company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported DLTH revenue for 2026-02-01 was $565.2M. Net income was -$16.4M. Revenue was down 9.8% from 2025-02-02 to 2026-02-01. DLTH currently screens at market cap $74.0M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DLTH currently screens at market cap $74.0M.
Not investment advice. Open the ALNY and DLTH stock pages for the full models.
Not investment advice.